Coaptite – Enrollment Closed A post –approval study to assess the long term safety and effectiveness Coaptite for the treatment of female urinary incontinence. Inclusion Criteria: Has female urinary stress incontinence that is due to intrinsic sphincter deficiency Has a baseline pas weight of >50 grams Age > 18 years Has a viable mucosal lining [...]
Eli Lilly (TSAT)-Enrollment closed A randomized, double blind, placebo controlled parallel study with an open label extension to assess the impact of testosterone solution on total testosterone, sex drive and energy in hypogonadal men. Inclusion Criteria: Age > 18 years Total testosterone level <300ng/dl obtained at each of the 2 screening visits Currently have at [...]
Rapaflo (Watson) Laboratories-Open for enrollment A prospective, multi center evaluation of the urodynamic benefits of Silodosin in men with bladder outlet obstruction associated with benign prostatic hyperplasia. Inclusion Criteria: Age > 45 years Has a diagnosis of benign prostatic hyperplasia(BPH) Has experienced lower urinary tract symptoms associated with BPH for at least 3 months prior [...]
Cedars-Sinai Office Towers Phone: 310-854-9898 8635 West 3rd Street Fax: 310-854-0267 Suite 1 West Los Angeles, CA 90048 Tower Urology Medical Group is located just West of The Beverly Center. Cedars-Sinai Medical Center is [...]
by: Dudley S. Danoff, MD, FACS The marketing of low serum testosterone (low T) as a common medical condition helped propel sales of testosterone gels, patches, injections, and tablets to about $2 billion in the United States last year, according to IMS Health, a health-care information company. A recent study published in the Medical Journal [...]
By Gary E Leach, M.D.Director, Tower Urology Institute for ContinenceTower UrologyLos Angeles, CA Loss of bladder control (urinary incontinence) after prostate surgery is a devastating complication, which has a significant negative impact on quality of life. The ‘good news’ is that with appropriate evaluation and treatment, the incontinence problem is usually treatable with significant improvement [...]
by Dudley S. Danoff, MD, FACS Over the past several years, the media has bombarded us with various treatments for low serum testosterone in men to prevent andropause, the male equivalent of menopause in women. But in a recent study published in the New England Journal of Medicine, Dr. Joel Finkelstein of Massachusetts General Hospital pointed [...]
by David Y. Josephson, MD, FACS For years, internists, endocrinologist and urologists alike have touted the benefits of testosterone replacement in men due to its protective affects on the cardiovascular system. Clinical trials had previously consistently shown improvements in a number of cardiac outcomes and reduction in adverse cardiovascular events (i.e. stroke, heart attack or death) [...]
by Dudley S. Danoff, MD, FACS Laparoscopic, robot-assisted surgery has grown dramatically, increasing more than 400 percent in the United States between 2007 and 2011. About 1,400 da Vinci systems, which cost $1.5 million to $2.5 million each, have been purchased by hospitals, according to the manufacturer of the da Vinci unit. A recent article in [...]
